News & Activities

What is Horizon Europe?Horizon Europe is not a funding agency, but rather a funding framework established by the European Union (EU) to support research and innovation across various fields.Read more at https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe_enWhat is Horizon Europe?Horizon Europe is the EU’s key funding programme for research and innovation. Following the Multiannual Financial Framework Midterm Review (MTR) decision, the indicative funding amount for Horizon Europe for the period 2021-2027 is EUR 93.5 billion.It tackles climate change, helps to achieve the UN’s Sustainable Development Goals and boosts the EU’s competitiveness and growth.The programme facilitates collaboration and strengthens the impact of research and innovation in developing, supporting and implementing EU policies while tackling global challenges. It supports creating and better dispersing of excellent knowledge and technologies.It creates jobs, fully engages the EU’s talent pool, boosts economic growth, promotes industrial competitiveness and optimises investment impact within a strengthened European Research Area.Legal entities from the EU and associated countries can participate.Key details about Horizon Europe:Nature of Horizon Europe:It is a 7-year research and innovation program (2021-2027).It has a total budget of €95.5 billion.It focuses on addressing global challenges, such as climate change, health, digital technologies, and more.Role:It serves as a funding framework for researchers, universities, industries, SMEs, and organizations within the EU and associated countries.It does not distribute funds directly but is managed by the European Commission and its agencies, such as the European Research Executive Agency (REA).Related Funding Agencies: Horizon Europe collaborates with funding agencies or entities responsible for allocating funds for specific projects, including:European Research Council (ERC): Supports frontier research.Marie Skłodowska-Curie Actions (MSCA): Focuses on researcher development and international collaboration.Innovation Fund: Provides funding for innovative projects.Conclusion:Horizon Europe is not a funding agency but a funding framework managed by the European Commission to promote research and innovation in Europe and internationally.Countries in ASEAN can apply for funding from Horizon Europe in certain cases, depending on the type of project and the country’s status within the Horizon Europe framework. Here’s a detailed explanation:1. ASEAN Countries and EligibilityASEAN countries are not EU Member States or Associated Countries:Countries in ASEAN such as Thailand, Malaysia, Singapore, Indonesia, and Vietnam are categorized as Third Countries (non-EU and non-Associated Countries).Third Countries Status:Researchers or organizations from these countries can still participate as partners with teams from EU Member States or Associated Countries.2. Conditions for Third CountriesMost ASEAN countries are not eligible for direct funding from Horizon Europe (non-eligible for funding). However, they can collaborate with European teams in specific projects.Example:A research team in Thailand can join as a partner in a project with a European team.Collaborations are typically focused on global challenges, such as climate change, biodiversity, or health.Some ASEAN countries may be supported in certain cases, such as Low- and Middle-Income Countries, as defined by Horizon Europe.3. Examples of ASEAN ParticipationVietnam: Often supported under topics related to sustainable development.Singapore: Can participate as a Third Country, though not eligible for direct funding, it can still contribute as a partner in significant research projects.Thailand: Research teams from Thailand often join through International Cooperation in areas related to regional issues, such as renewable energy or environmental conservation. 4. Recommendations for ASEAN Countries Applying for Horizon Europe FundingBuild collaborations with teams from EU or Associated Countries:This increases the chances of participation and funding opportunities.Focus on projects addressing global challenges:For example, climate change, health innovation, or food security.Review specific project requirements:Some projects may allow ASEAN countries to participate and receive funding.

Hosting InformationOffer Deadline: Thu, 11 Sep 2025 - 23:59Organisation / Company: Monash University MalaysiaCountry: MalaysiaWebsitehttps://www.lancaster.ac.uk/health-and-medicine/https://www.monash.eduEmail- s.r.hall@lancaster.ac.uk- yap.michelle@monash.edu DescriptionBackgroundWe seek highly motivated postdoctoral researchers to submit expressions of interest (EOI) for a 3-year Marie Sklodowska-Curie Actions (MSCA) Postdoctoral Global Fellowship in drug development for snake venom toxins-induced necrosis. This prestigious fellowship offers an excellent opportunity for career development and international attachment in pharmacology and toxinology research. The fellowship also opens opportunities for international collaborations between Asia-Pacific and the EU. This fellowship also fosters early career development support. The candidate will lead innovative research projects in drug development for toxin envenomation, including mechanistic actions, structure-activity relationships, and preclinical assessment. Upon successful application, you will be hosted in Monash University Malaysia (Dr Michelle Yap – Toxin Pharmacology Lab) for 2 years and 1 year at Lancaster University (Dr Steve R Hall). Eligibility:Must hold a PhD in pharmacology, toxinology, biomedical science, biochemistry or biology-related field at the time of application. Meets MSCA requirements for this Global Fellowship: The applicant must be national or long-term resident (5 years+) of an EU Member State or Horizon Europe Associated Country. Demonstrates an excellent track record of publications. Demonstrates proficiency in research, laboratory, and data analysis skills; bioinformatics knowledge is an added advantage. Demonstrates proficiency in writing and communication skillsDemonstrates ability to work effectively in a team. To express interest, please submit a CV, and motivation to apply with two recommendation letters from academic supervisors or collaborators. We will contact the shortlisted candidate to prepare for the application. Closing Date for Applications:To allow ample preparation time for application and proposal writing, we anticipate the closing date to be 31st March 2025. However, please note that the call will remain open until a suitable candidate is found. Early submissions are encouraged.

Call for Expression of Interest for MSCA Postdoctoral fellowships at UNIGE – N. 7 Optimization and machine learningHosting InformationOffer Deadline: Mon, 5 May 2025 - 13:00Organisation / Company: University of GenoaLink: https://euraxess.ec.europa.eu/jobs/hosting/call-expression-interest-msca-postdoctoral-fellowships-unige-n-7-optimization-andUniversity of Genoa, UNIGE, located in Genoa, ITALY, welcomes postdoctoral researchers of any nationality, with an excellent track record, to apply to the European Commission Marie Sklodowska-Curie (MSCA) Postdoctoral Fellowships 2025. Our University has been beneficiary of several MSCA-PF in Horizon 2020 and Horizon Europe. The Marie Sklodowska Curie (MSCA) Postdoctoral Fellowship is one of funding scheme of the European Commission’s Horizon Europe Research & Innovation programme, dedicated to excellent research promoting international mobility, as well as interdisciplinary and intersectoral exchanges. MSCA fellowship grant provides a competitive salary plus mobility and family allowances if applicable, as well as a contribution to cover research, training and networking costs. The research projects will have 2- or 3-years duration. Selected candidates will be provided with special support for proposal writing and development. The University of Genoa will organize in May the fifth edition of the Masterclass MSCA@UniGe. Selectedcandidate researchers will have the opportunity to attend a 2-days online intensive training and coaching course on how to write a successful proposal. This masterclass is a pathway of support to candidates and their supervisors in preparing project proposal, including prescreening activity of the draft proposals and the organisation of dedicated B2B meetings, by the European Research Office of UniGe, National Contact Point and other experts.The masterclass will take place on May/June2025.More information: Masterclass MSCA@UniGeMSCA domain: Mathematics (MAT)Research Project DescriptionI work in the field of optimization for machine learning and inverse problems. My main interest is the development and the application of mathematical optimization techniques to enhance the performance, efficiency, and interpretability of models and algorithms. Optimization plays a crucial role in the of training machine learning models. The goal is to minimize an empirical error, which is an approximation of the true objective function, perturbed by stochastic noise. In modern applications, the problem is often high dimensional, and most successful optimization methods are based on simple iterative procedures, such as gradient descent or stochastic gradient descent. I am interested in many challenges related to the behavior of gradient based methods such as: convergence in the nonconvex setting, implicit regularization properties, scalable, adaptive, asynchronous and distributed implementations.Research GroupMaLGa is a joint research center between computer science and mathematics. Its activities span a wide range of diverse but connected topics, including Computer Vision, Computational Harmonic Analysis, Data Science, Statistical Learning and Optimization.ApplicationAn expression of interest shall be sent to prof. Silvia Villa (silvia.villa@unige.it, Orcid ID: 0000-0002-6232-5631) within 5th May 2025.Your file should contain the following elements:A short CVA one-page research proposalOne/two letters of reference (optional)For more information, please contact prof. Silvia Villa (silvia.villa@unige.it).EligibilityFor MSCA-PF 25 call (opening foreseen on 9th April 2025), at the deadline for the submission of proposals (10th September 2025) postdoctoral candidates shall have a maximum of 8 years of postdoctoral research experience and must not have resided or carried out their main activities in Italy (for European Fellowship) or in the Third Country of the outgoing phase (for Global Fellowship) for more than 12 months in the 3 years immediately prior to the abovementioned deadline. More info on MSCA PF are available at the following link: https://marie-sklodowska-curie-actions.ec.europa.eu/actions/postdoctora…

Accelerating uptake through open proposals for advanced SME innovation (HORIZON-CL3-2024-SSRI-01-02)Programme: Horizon Europe Framework Programme (HORIZON)Opening date: 27 June 2024Deadline date: 20 November 2024 17:00:00 Brussels timeTopic descriptionExpectedOutcome:Projects’ results are expected to contribute to some or all of the following outcomes:Development of a mature technological solution addressing EU security policy priorities in the areas addressed by the Cluster 3 work programme;Facilitated access to civil security market for small innovators;Improved cooperation between public buyers and small supply market actors for a swifter uptake of innovation in response to short to mid-term needs;Stronger partnerships between small and medium EU security industry and technology actors to ensure the sustainability of the EU innovation capacity in the civil security domain and reduce technological dependencies from non-EU suppliers in critical security areas.Scope:Europe’s 25 million small and medium enterprises (SMEs) are the backbone of the EU economy. SMEs can bring innovation to societal challenges, including the security of EU citizens. Innovative SMEs and high-tech start-ups can transform and modernise EU security capabilities.However, despite the innovation capacity of EU SMEs, these often experience difficulties in finding their way to the public markets. These include red tape in public contracts, access to new customers, access to finance, industrial competition and IP valorisation. These difficulties are exacerbated in markets that show restrictions of different kind, as it is the case of security.Knowing that SMEs require additional support to reach the security buyers and that the collaboration opportunities offered by the projects of the Pillar II of Horizon Europe can be a catalyst for uptake, this topic aims to offer a collaborative environment for small and medium innovators to tailor their innovations to the specific needs of civil security end-users.Applicants are invited to submit proposals for technology development along with the following principles:Focus on mature technological solutions addressing EU security policy priorities in the areas addressed by the Cluster 3 work programme.Not overlapping with the scope of the topics included in the other destinations of this work programme.Fostering collaboration between SMEs from different Member States and Associated Countries.Involving security end-users in the role of validator and potential first-adopter of the proposed innovations.Fostering collaboration schemes between small companies and research and technology organisations and/or big industrial players aimed at fostering innovative technology transfer or creating innovative business models that facilitate access to market and strengthen the innovation capacity of EU SMEs and start-ups in the domain of civil security.Examples of activities to plan in the proposed projects include, but are not limited to: assimilating market requirements; facilitating access to additional funding; approaching potential public buyers; assess competitive landscape; supporting in innovation management (methodological and process innovation, business model innovation, market innovation); assist in IP management and exploitation; provide guidance for expansion to future markets, etc.The participation of research and technology organisations should not focus on own technology development but on supporting the small industrial players in accelerating the technology transfer of innovative security solutions for their further development and production.It is encouraged that one SME takes the coordinator role[1]. Exceptions to this requirement should be duly justified.The projects should have a maximum estimated duration of 2 years.Under this topic, projects should address the one of the following areas of Fighting Crime and Terrorism (FCT, Option A), Disaster-Resilient Society (DRS, Option B), Resilient Infrastructure (INFRA, Option C) Border Management (BM, Option D). Some examples of domains that could be addressed:.Option A: Some examples of domains that could be addressed under the FCT area are: (indicative and non-exhaustive): mobile forensics; deepfake detection; detection of counterfeiting (fake items, fake currency bills) or of falsified/forged documents (passports, ID cards); detection and countering of advanced forms of malware, as well as non-cash payment frauds and other cyber-scams.Option B: Some examples of domains that could be addressed under the DRS area are (indicative and non-exhaustive): data and satellite/remote sensing information exploitation, positioning and localisation tracking and tracing, monitoring and surveillance for disaster prevention.Option C: some examples of domains that could be addressed under the INFRA area are: (indicative and non-exhaustive): physical access control, autonomous systems used for infrastructure protection, positioning and localisation tracking and tracing, monitoring and surveillance of environments and activities.Option D: under the BM area are (indicative and non-exhaustive): facilitated border checks; secure documents and identity management for border crossings; border surveillance; detection of drugs, explosives, Chemical, Biological, Radiological and Nuclear (CBRN), weapons and/or other dangerous materials in customs environment; detection of stolen, smuggled, illicit or illegal goods (cigarettes, art, cultural goods, wildlife) in a customs environmentIn this topic, projects should address the EU security policy priorities in the areas addressed by the Cluster 3 work programme.In this topic, the integration of the gender dimension (sex and gender analysis) in research and innovation content should be addressed only if relevant in relation to the objectives of the research effort.Specific Topic Conditions:Activities are expected to achieve TRL 6-7 by the end of the project – see General Annex B.[1]If a MIDCAP is included in the proposal, it could also take the role of coordinator.Eligible countries: described in Annex B of the Work Programme General AnnexesA number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.Other eligibility conditions: described in Annex B of the Work Programme General AnnexesThe following additional eligibility conditions apply:Consortia must include, as beneficiaries:- A minimum of three (3) to a maximum of seven (7) partners.- At least 2 SMEs from 2 different Member States.- At least 1 end-user organisation in the areas addressed by the proposal, namely one of the following options:Option A "Fighting Organised Crime and Terrorism’’Option B ‘"Disaster-Resilient Society’’Option C "Resilient Infrastructure’’ andOption D ‘"Border Management’’, provided that the applications attain all thresholds.- At least 2 Member States must be represented in the consortium.Participation of non-SME industries and Research and Technology Organisations (RTOs) is not excluded, but it must be limited to 15% of the budget.At least 50% of the budget must be allocated to SMEs.The following exceptions apply: subject to restrictions for the protection of European communication networks.

AboutThe current Expression of Interest is intended for searching post-doctoral candidates with interest in applying for the Marie Skłodowska-Curie GLOBAL Postdoctoral Fellowship 2024 (HORIZON-TMA-MSCA-PF-GF) at AO Research Institute Davos (ARI, Switzerland) as Host Institution for the outgoing phase (12-24 months), followed by a mandatory 12-month return phase to a host institution based in an EU Member state / Associated Country.NOTE: Being Switzerland currently classified as “not associated third country”, it is NOT possible to apply for MSCA European Postdoctoral Fellowships with a Swiss host. It is only possible to apply for GLOBAL Fellowship with the Swiss host in the outgoing phase.Call deadline is 11 September 2024.Potential candidates must comply with the following eligibility criteria of the MSCA Postdoctoral Fellowship callHorizon Europe MSCA - How to apply - European Commission (europa.eu)To be National or long-term resident (5 consecutive years spent in an EU Member state / Associated Country),To be in possession of the PhD at the call deadline,To have a maximum of 8 years of research experience at the call deadline (few exceptions are possible),To comply with the mobility rule: do not have resided or carried out the main activity (work or studies) in the country of the Host Institute during the outgoing phase (Switzerland) for more than 12 months in the 3 years before the call deadline.In case of resubmission, to have not received in the previous application a lower score than 70%.Description of the host organization and research groupThe AO Foundation is a medically guided, not-for-profit organization, a global network of surgeons, and the premier education, innovation, and research organization for the surgical treatment of trauma and musculoskeletal disorders.AO Research Institute Davos (ARI) is the research arm of AO Foundation; its mission is promoting excellence in patient care and outcomes in trauma and musculoskeletal disorders. ARI's scientific activities are multidisciplinary and with a very strong approach to basic and translational research, focused on clinical applications and realized through a cooperation network with many industrial partners. ARI has a vast experience in managing and supervising research projects with a portfolio of international (H2020, Horizon Europe) and national (SNSF) competitive projects. In addition, ARI is at the forefront of high-quality international conferences, such as EORS 2010, TERMIS 2017, ESB 2023, and the next EORS 2025. ARI's commitment in fulfilling the highest standards in research is demonstrated by international standard accreditations. The entire ARI is certified according to ISO 9001:2015. The accreditation includes ARI's preclinical facility, which can perform GLP-like studies. Additionally, the Biomechanical Services and Concept Development are certified as medical device manufacturer according to ISO 13485:2016. Also, ARI's preclinical facility fulfils the highest standard of care for animals (AAALAC accreditation).ARI comprises of 3 Research Programmes:Regenerative Orthopaedics (RO) is a multidisciplinary team focusing on a holistic approach to tissue engineering for repair and regeneration of the musculoskeletal system. RO Program has established research activities in the field of bone, cartilage, and intervertebral disc, with a major focus on regenerative medicine, 3D printing, cell and gene therapy and fracture-related infections.The RO comprises of 5 focus areas: Disc & Cartilage Biology area has tissue-specific bioreactors, namely for intervertebral disc and articular joints, that are instrumental for in vitro testing and for investigating the effect of mechano-regulation on cell behaviour.Bone Biology area aims to study the cellular mechanisms involved in the different phases of bone healing and their interplay for a better understanding and further monitoring of the process.Biomedical Materials area develops responsive materials for orthopaedic regeneration with a strong expertise on biopolymers and nanocomposites. Additive manufacturing technologies are used for both basic understanding of biomaterials and cells interaction, and for translational research in the orthopaedic field.Progenitor Biology & Mechanoregulation area investigates the role of multiple stimuli, such as mechanical stimulation, growth factors and gene therapy in the progression of stem cell differentiation.Infection Biology area performs research into clinically relevant preclinical models of fracture related infection including both in vitro and in vivo models, which are used to investigate novel anti-infective interventions such as implant coatings, novel antimicrobials and provide improved understanding of host-pathogen interactions.Sound Guided Tissue Regeneration activities are articulated around the translation of innovative biofabrication technologies for the repair of musculoskeletal disorders and development of cutting-edge 3D in vitro models for drug screening and personalized medicine. The team use sound wave-based approach and other external fields (e.g. light, magnetic, electric) for contactless cell assembly and stimulation. ARI supported the startup Mimix Biotherapeutics which launched the first acoustic bioprinter in 2021. Biomedical Development (BD) offers extensive know-how, expertise, and experience in the fields of biomechanical testing and computational analyses to advance patient care.Preclinical Service (PCF) offers strong expertise and applies animal models to answer questions from academic researchers, clinicians and industrial partners to improve fracture fixation devices, investigate new (bio)-materials and technologies as well as and surgical procedures. Detailed analysis, both from in vitro and in vivo studies is also provided by the Tissue Morphology facility, which is the institutes' core facility for histology and microscopy.How to apply?Interested candidates should send their CV and a motivation letter to Nunzia Di Luise, Scientific Project Officer (nunzia.diluise@aofoundation.org).More Informationhttps://www.aofoundation.org/what-we-do/research-innovation/about